JJJohn Taylor Jenkins

John Taylor Jenkins

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


John Taylor Jenkins has a total of 164 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Futility in cancer surgery: towards consensus and patient-centred decisions

    by Alison Wallace, Campbell S Roxburgh, Colin W Steele, John T Jenkins

  • Open Access

    MRI prognostic features in rectal cancer neoadjuvant trials: A systematic review of reporting gaps across two decades

    by Nikhil Lal, Kenneth Jordan Ng Cheong Chung, Nicola Hodges, John T. Jenkins, Gina Brown

    Background: Magnetic resonance imaging (MRI) is central to staging and treatment planning in rectal cancer, particularly in identifying candidates for neoadjuvant therapy. Prognostic MRI features such as tumour depth (mrT), extramural venous invasion (EMVI) and tumour deposits (TDs) are increasingly recognised as markers of systemic risk, yet their reporting in randomised controlled trials (RCTs) remains unclear. This systematic review aimed to evaluate the reporting frequency, consistency and integration of pre‐treatment MRI prognostic variables in RCTs assessing neoadjuvant treatment for rectal cancer. Methods: A systematic search was conducted across MEDLINE, EMBASE, Web of Science and CENTRAL from 01 January 2005 to 18 November 2025. RCTs evaluating neoadjuvant strategies in adult patients with resectable rectal cancer were included. Two reviewers independently extracted data on MRI variables, protocol details and trial design. PRISMA guidelines were followed. Results: Of 1,283 screened studies, 34 RCTs met inclusion criteria. All studies reported mrT, and 33 (97%) included nodal staging (mrN). mrEMVI was reported in only 10 trials (29.4%), and mrT substage was reported in 5 studies (14.7%). MRI protocols were inconsistently described, with only 5 trials specifying acquisition parameters. Only 10 studies incorporated EMVI into risk stratification frameworks. Four trials did not mandate MRI for baseline staging. Conclusion: Despite MRI's critical role in rectal cancer management, key prognostic features such as EMVI/TDs and mrT substage are underreported. This omission risks poor risk stratification, trial imbalance and misinformed clinical guidance. Standardisation of MRI reporting is urgently needed to enhance trial validity and optimise personalised treatment strategies.


  • Open Access

    Gluteal Flap Reconstruction Following Complex Rectal Cancer Surgery: A Large Consecutive Series of Perineal Wounds Exploring Risk Factors for Complications

    by Laura E. Gould, Edward. T. Pring, Ioanna Drami, Joannis Constantinides, Nicola Hodges, Colin W. Steele, Campbell S.D. Roxburgh, Elaine M. Burns, John T. Jenkins

    Aim: To determine whether high complexity pelvic exenterations alter perineal wound morbidity and to assess risk factors for perineal flap complications following complex rectal cancer surgery. Methods: A retrospective analysis of consecutive adults undergoing complex rectal cancer resections with immediate gluteal flap perineal reconstruction between January 2013‐July 2021 at a tertiary referral centre. Conventional complex cancer resections were compared with “high complexity” exenterations, including en bloc sacrectomy and extended lateral pelvic side wall excision. Primary outcomes were short‐term (wound infection, necrosis, dehiscence) and long‐term (sinus, fistula, hernia) perineal flap complications. Results: We identified 194 patients (median 56 years, 60% male) with gluteal flap reconstructions; 163 (84%) for advanced or recurrent rectal cancer. Gluteal artery perforator flaps were predominantly used (176, 92%). Wound infections were more common in the conventional group (23.2% vs. 6.3%, p = 0.001), but no other differences in complications were observed between groups. Obesity (HR 2.70, 95% CI 1.22–5.97, p = 0.014) and total pelvic exenteration (HR 2.13, 95% CI 1.07–4.23, p = 0.031) were associated with short‐term complications. Age over 65 years predicted readmission/reoperation (HR 2.66, 95%CI 1.07–6.6, p = 0.040). Ureteric/ileal conduit leaks were associated with long‐term complications (HR 3.37, 95% CI 1.21–9.34, p = 0.024). No flap losses occurred. Conclusion: Gluteal fasciocutaneous perforator flaps provide reliable perineal reconstruction after complex rectal cancer surgery. The extent of surgery and resulting defect size did not significantly influence perineal wound complication rates.

  • Exploring decision making for treatment in LARC and LRRC: A qualitative study

    by Anwen Williams, Claire O'NEill, Hayley Hutchings, Aaron Quyn, Michael Duff, John Ian Jenkins, Claire Taylor, Ben Griffiths, Dean Harris, Martyn Evans, et al.


  • Clinical determinants of outcome following pelvic exenteration for locally advanced or locally recurrent rectal cancer

    by Laura E. Gould, E Toby Pring, Alison Wallace, Nicola Hodges, Elaine M. Burns, Colin W. Steele, Campbell Sd. Roxburgh, John T. Jenkins


  • Enhancing decision-making and patient comprehension in complex rectal cancer surgery through personalized three-dimensional imaging: randomized feasibility study

    by Jordan A Fletcher, Alison Corr, Ioanna Drami, Claire Taylor, Therese Hona, David Burling, Phillip Lung, Elaine M Burns, John T Jenkins

    Background: Shared decision-making is essential for patient autonomy in complex rectal cancer requiring pelvic exenteration. Patients often lack understanding of procedures and risks, causing decisional conflict. Personalized three-dimensional (3D) models may improve patient education and decision-making. Methods: A single-centre mixed-methods randomized feasibility trial was conducted at St Mark’s Complex Cancer Clinic (June 2021–March 2022). Patients referred for pelvic exenteration were randomized 1 : 1 to standard consultation or standard consultation plus personalized 3D modelling. The primary qualitative objective explored patient engagement with 3D models through semi-structured interviews. The primary quantitative outcome assessed changes in decisional conflict scale (DCS) scores. Secondary outcomes included operative knowledge questionnaires and patient–surgeon agreement on functional outcomes. Results: Qualitative analysis showed that personalized 3D models enhanced patient understanding of complex anatomy, built trust, improved communication, and facilitated emotional processing. Quantitatively, a greater reduction occurred in DCS scores post-consultation in the 3D group (29 patients) compared with the standard group (22 patients) (median reduction of 36 versus 14 points; P = 0.005), though baseline scores differed. The 3D group demonstrated higher patient–surgeon agreement on functional outcomes (84% versus 60%; P < 0.001), despite greater operative complexity (median Pelvic Exenteration Lexicon score of 8 versus 4.5; P = 0.040). Conclusion: This feasibility study suggests that personalized 3D models may enhance comprehension and reduce decisional conflict in complex rectal cancer consultations. However, baseline differences between groups and lack of comparison with generic models limit definitive conclusions. Future research should address these methodological limitations and explore longer-term outcomes, such as decisional regret.


  • Open Access

    MRI radiomics prediction modelling for pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review and meta-analysis

    by Jason Rai, Dinh V. C. Mai, Ioanna Drami, Edward T. Pring, Laura E. Gould, Phillip F. C. Lung, Thomas Glover, Joshua D. Shur, Brandon Whitcher, Thanos Athanasiou, et al.

    Purpose: Predicting response to neoadjuvant therapy in locally advanced rectal cancer (LARC) is challenging. Organ preservation strategies can be offered to patients with complete clinical response. We aim to evaluate MRI-derived radiomics models in predicting complete pathological response (pCR). Methods: Search included MEDLINE, Embase and Cochrane Central Register of Controlled Trials (CENTRAL) and Cochrane Database of Systematic Reviews (CDSR) for studies published before 1st February 2024. The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) and Radiomics Quality Score (RQS) tools were used to assess quality of included study. The research protocol was registered in PROSPERO (CRD42024512865). We calculated pooled area under the receiver operating characteristic curve (AUC) using a random-effects model. To compare AUC between subgroups the Hanley & McNeil test was performed. Results: Forty-four eligible studies (12,714 patients) were identified for inclusion in the systematic review. We selected thirty-five studies including 10,543 patients for meta-analysis. The pooled AUC for MRI radiomics predicted pCR in LARC was 0.87 (95% CI 0.84–0.89). In the subgroup analysis 3 T MRI field intensity had higher pooled AUC 0.9 (95% CI 0.87–0.94) than 1.5 T pooled AUC 0.82 (95% CI 0.80–0.83) p < 0.001. Asian ethnicity had higher pooled AUC 0.9 (95% CI 0.87–0.93) than non-Asian pooled AUC 0.8 (95% CI 0.75–0.84) p < 0.001. Conclusion: We have demonstrated that 3 T MRI field intensity provides a superior predictive performance. The role of ethnicity on radiomics features needs to be explored in future studies. Further research in the field of MRI radiomics is important as accurate prediction for pCR can lead to organ preservation strategy in LARC. Graphical


  • Open Access

    A Scoping Review of the Implications and Applications of Body Composition Assessment in Locally Advanced and Locally Recurrent Rectal Cancer

    by Dinh Van Chi Mai, Ioanna Drami, Edward T. Pring, Laura E. Gould, Jason Rai, Alison Wallace, Nicola Hodges, Elaine M. Burns, John T. Jenkins, on behalf of the BiCyCLE Research Group

    Background: A strong body of evidence exists demonstrating deleterious relationships between abnormal body composition (BC) and outcomes in non-complex colorectal cancer. Complex rectal cancer (RC) includes locally advanced and locally recurrent tumours. This scoping review aims to summarise the current evidence examining BC in complex RC. Methods: A literature search was performed on Ovid MEDLINE, EMBASE, and Cochrane databases. Original studies examining BC in adult patients with complex RC were included. Two authors undertook screening and full-text reviews. Results: Thirty-five studies were included. Muscle quantity was the most commonly studied BC metric, with sarcopenia appearing to predict mortality, recurrence, neoadjuvant therapy outcomes, and postoperative complications. In particular, 10 studies examined relationships between BC and neoadjuvant therapy response, with six showing a significant association with sarcopenia. Only one study examined interventions for improving BC in patients with complex RC, and only one study specifically examined patients undergoing pelvic exenteration. Marked variation was also observed in terms of how BC was quantified, both in terms of anatomical location and how cut-off values were defined. Conclusions: Sarcopenia appears to predict mortality and recurrence in complex RC. An opportunity exists for a meta-analysis examining poorer BC and neoadjuvant therapy outcomes. There is a paucity of studies examining interventions for poor BC. Further research examining BC specifically in patients undergoing pelvic exenteration surgery is also lacking. Pitfalls identified include variances in how BC is measured on computed tomography and whether external cut-off values for muscle and adipose tissue are appropriate for a particular study population.


  • Rectal cancer surgery: radiology roadmaps

    by Edward T Pring, David N Burling, Thomas E Glover, John T Jenkins


  • Open Access

    Developing a curriculum for advanced fellowship training in complex cancer for the UK

    by Helen Mohan, Deena Harji, Ioanna Drami, Ben Griffiths, Kirsten Larkins, Kirsten Boyle, Ian R. Daniels, Richard Baker, John T. Jenkins

    Aim: Surgery for complex colorectal cancer is elaborate: preoperative assessment, patient selection, radiological interpretation, operative strategy, operative technical skills, operative standardization, postoperative care and management of complications are all critical components. Given this complexity, training that encompasses all these crucial aspects to generate suitably edified surgeons is essential. To date, no curriculum exists to guide training in advanced and recurrent pelvic malignancy, particularly for complex colorectal cancer. Such a curriculum would potentially offer numerous advantages, not only for individual surgeons but also for research, governance, international collaboration and benchmarking. The aim of this study was to design and develop a framework for a curriculum for fellowship training in complex colorectal cancer that encompasses pelvic exenteration surgery.Method: Kern described a six‐step method for curriculum design that is now widely adopted in medical education. Our study utilizes steps 1–4 of Kern's method to develop a syllabus and assessment framework for curriculum development for fellowship training in complex colorectal cancer encompassing pelvic exenteration. A literature review was conducted to address step 1, followed by targeted needs assessment in step 2 by conducting focus groups with trainees, fellows and experts to identify learning needs and goals with objective setting for step 3. An expert consensus group then voted on these recommendations and developed educational strategy recommendations as step 4. For the purposes of brevity, ‘pelvic exenteration’ in the text is taken to also encompass extended and multivisceral resections that fall under the remit of complex [colorectal] cancer.Results: Step 1 of Kern's method identified a gap in the literature on curricula in complex cancer surgery. Step 2 identified key areas regarded as learning needs by trainees, including anatomy, hands‐on experience and case volume. Step 3 defined the goals and objectives of a fellowship curriculum, defined in six domains including theoretical knowledge, decision‐making, technical skills, postoperative management and continuing professional development. Finally, as a prelude to stages 5 and 6, a strategy for implementation and for feedback and assessment was agreed by an expert consensus meeting that defined case volume (a minimum of 20 pelvic exenteration operations within a fellowship period) and coverage of this syllabus with derived metrics.Conclusions: Our working group has developed a curriculum framework for advanced fellowship training in complex cancer in the UK. Validation is needed through implementation, and affirmation of its utility, both nationally and internationally, must be sought.